Teens with diabetes cope with the additional burden of CV protection

ACE inhibitors and statins are well tolerated in teenagers with Type 1 Diabetes but more evidence is required to demonstrate whether they are effective

ACE inhibitors and statins are well tolerated in teenagers with Type 1 Diabetes but more evidence is required to demonstrate whether they are effective in preventing rapid increases in albumin excretion and associated complications leading to cardiovascular disease.

Read the limbic's , an editorially independent publication for healthcare professionals, interview with Children's Diabetes Centre co-director Professor Tim Jones, here.

First published Tuesday 5 December 2017.